Full Schedule

7:00 AM – 8:00 AM CEST

Coffee with Exhibitors

Location: Hall C

7:00 AM – 8:00 AM CEST

Poster Session C Set-Up

Location: Hall C

7:00 AM – 3:30 PM CEST

Speaker Ready Room

Location: Meeting Room 21

7:00 AM – 4:30 PM CEST

Lactation Room

Location: Meeting Room 28

7:00 AM – 4:30 PM CEST

Registration

Location: Hall F6-F7 Lobby

8:00 AM – 3:15 PM CEST

Poster Session C

Location: Hall C

8:00 AM – 4:30 PM CEST

Exhibits

Location: Hall C

8:30 AM – 10:00 AM CEST

Methods: Validation

Location: Congress Hall D5

Moderator: – UCL

Moderator: – Eli Lilly & Company

Methods in Pharmacoepidemiology

8:30 AM – 8:45 AM CEST

Validation of an International Classification of Disease (ICD) 10 Algorithm for Hypoglycemia in Administrative Claims Data

Location: Congress Hall D5

Presenting Author: – University of North Carolina at Chapel Hill

Co-Author: – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

Co-Author: – Department of Population Health Sciences, Weill Cornel Medical College

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – Endocrinology Service, Department of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center

Safety End Points

8:45 AM – 9:00 AM CEST

Evaluation of Mortality Data Sources Compared to the National Death Index in the Healthcore Integrated Research Database

Location: Congress Hall D5

Presenting Author: – HealthCore, Inc.

Co-Author: – HealthCore, Inc.

Co-Author: – HealthCore Inc.,

Co-Author: – HealthCore, Inc.

Co-Author: – HealthCore inc.

Co-Author: – Merck KGaA

Co-Author: – HealthCore, Inc.

Methods in Pharmacoepidemiology

9:00 AM – 9:15 AM CEST

Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System

Location: Congress Hall D5

Presenting Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA

Co-Author: – Regeneron Pharmaceuticals

Co-Author: – 4. Division of Endocrinology, Diabetes, & Metabolism, College of Medicine, University of Florida

Co-Author: – University of Florida

Methods in Pharmacoepidemiology

9:15 AM – 9:30 AM CEST

Reproducibly Estimating Drug Exposure from Free-text Prescriptions

Location: Congress Hall D5

Presenting Author: – The University of Manchester

Co-Author: – The University of Manchester

Co-Author: – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

Co-Author: – Centre for Epidemiology Versus Arthritis

Co-Author: – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

Co-Author: – Department of Computer Science, University of Manchester

Methods in Pharmacoepidemiology

9:30 AM – 9:45 AM CEST

A Bootstrap Approach for Validating Groups Identified by Latent Class Growth Models

Location: Congress Hall D5

Presenting Author: – Laval University

Co-Author: – Université Laval

Co-Author: – Laval University

Methods in Pharmacoepidemiology

9:45 AM – 10:00 AM CEST

Can Administrative Claims Data Be Used to Determine Pre-treatment HbA1c Among Adults with Type 2 Diabetes?

Location: Congress Hall D5

Presenting Author: – Harvard Medical School & Harvard Pilgrim Health Care Institute

Co-Author: – Harvard Medical School Department of Population Medicine

Co-Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute

Co-Author: – Harvard Pilgrim Health Care Institute

Methods in Pharmacoepidemiology

8:30 AM – 10:00 AM CEST

Examining Equity: Who? Where and What?

Location: Congress Hall D2

Moderator: – AstraZeneca

Moderator: – The Ohio State University

Health Equity

8:30 AM – 8:45 AM CEST

Inequalities in the Incidence and Management of Non-valvular Atrial Fibrillation in England, 2009 to 2019: Cohort Study Using Electronic Health Records from General Practices

Location: Congress Hall D2

Presenting Author: – Division of Population Health, Health Services Research & Primary Care, University of Manchester

Co-Author: – Division of Population Health, Health Services Research & Primary Care, University of Manchester

Co-Author: – Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester M13 9PL, UK

Co-Author: – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK

Co-Author: – Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), The University of Manchester, Manchester M13 9PL, UK

Co-Author: – Department of Health Sciences, Seebohm Rowntree Building, University of York, York, UK

Co-Author: – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK

Co-Author: – Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK

Co-Author: – Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester M13 9PL, UK

Disease Epidemiology/Clinical Course

8:45 AM – 9:00 AM CEST

Racial Disparities in Clinical Trial Participation: Evidence from Real World Oncology Data

Location: Congress Hall D2

Presenting Author: – Flatiron Health

Co-Author: – Flatiron Health

Co-Author: – Jenny Guadamuz

Health Equity

9:00 AM – 9:15 AM CEST

Socioeconomic Inequalities in COVID-19 Vaccination and Infection Among Adults Living in Urban Areas of Catalonia, Spain: A Population-based Cohort Study

Location: Congress Hall D2

Presenting Author: – Institut Universitari d�Investigaci� en Atenci� Prim�ria Jordi Gol

Co-Author: – IDIAPJGol, UAB

Co-Author: – IDIAPJGol; NDORMS, University of Oxford

Co-Author: – IDIAPJGol, Barcelona, Spain

Co-Author: – CSM, NDORMS, University of Oxford

Co-Author: – IDIAPJGol, Barcelona, Spain

Health Equity

9:15 AM – 9:30 AM CEST

Geographic Variation and Racial Disparities in Novel Glucose-lowering Drugs Adoption Among US Medicare Beneficiaries with Type 2 Diabetes

Location: Congress Hall D2

Presenting Author: – University of Florida

Co-Author: – 1. Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida

Co-Author: – 2. Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida

Co-Author: – 1. Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida

Co-Author: – 4. Division of Endocrinology, Diabetes, & Metabolism, College of Medicine, University of Florida

Co-Author: – 2. Department of Pharmacotherapy & Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, United States

Co-Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Health Equity

9:30 AM – 9:45 AM CEST

The Association of Ethnicity and Social Deprivation and Choice of Second-line Antidiabetic Treatment in People with Type 2 Diabetes: A Cross-sectional Study

Location: Congress Hall D2

Presenting Author: – London School of Hygiene and Tropical Medicine

Co-Author: – LSHTM

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – University of Washington School of Pharmacy

Co-Author: – University College London

Co-Author: – National Institute for Health Research

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – University of Oxford

Co-Author: – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT

Co-Author: – University of Leicester

Co-Author: – London School of Hygiene and Tropical Medicine

Health Equity

9:45 AM – 10:00 AM CEST

Differences in Opioid Use After Hip Fracture by Race and Post-acute Care Use Among U.S. Older Adults

Location: Congress Hall D2

Presenting Author: – Brown University School of Public Health

Co-Author: – Brown University School of Public Health

Co-Author: – Brown University

Co-Author: – Lifespan / Rhode Island Hospital

Health Equity

8:30 AM – 10:00 AM CEST

Pandemic Prescription Patterns (Plus Pneumonia!)

Location: Congress Hall D4

Moderator: – University of North Carolina at Chapel Hill

Moderator: – University of Groningen

Drug Utilization Research

8:30 AM – 8:45 AM CEST

Does COVID-19 Pandemic Impacted on Quality of Antibiotic Use in the Community? An Interrupted Time-series Analysis

Location: Congress Hall D4

Presenting Author: – Faculty of Pharmacy University of Lisbon

Co-Author: – School of Medicine, University of Minho

Co-Author: – Faculdade de Farmácia da Universidade de Lisboa, Departamento de Farmácia, Farmacologia e Tecnologias em Saúde, Lisboa, Portugal

Co-Author: – Centre for Health Evaluation and Research, National Association of Pharmacies (CEFAR/Infosaude-ANF)

Co-Author: – Faculdade de Farmácia da Universidade de Lisboa, Departamento de Farmácia, Farmacologia e Tecnologias em Saúde, Lisboa, Portugal.

Co-Author: – Faculdade de Farmácia da Universidade de Lisboa, Departamento de Farmácia, Farmacologia e Tecnologias em Saúde, Lisboa, Portugal

Drug Utilization Research

8:45 AM – 9:00 AM CEST

Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings

Location: Congress Hall D4

Presenting Author: – US Food and Drug Administration

Co-Author: – US Food and Drug Administration

Co-Author: – U.S. Food and Drug Administration

Co-Author: – Acumen, LLC

Co-Author: – Acumen LLC

Co-Author: – Department of Veterans Affairs

Co-Author: – Harvard Pilgrim Health Care Institute

Co-Author: – Harvard Pilgrim Healthcare Institute

Co-Author: – Harvard Pilgrim Health Care Institute

Co-Author: – Aetion, Inc

Co-Author: – Aetion, Inc.

Co-Author: – CMS

Co-Author: – US Food and Drug Administration

Drug Utilization Research

9:00 AM – 9:15 AM CEST

Utilization of Broad- versus Narrow-spectrum Antibiotics for the Treatment of Outpatient Community-acquired Pneumonia

Location: Congress Hall D4

Presenting Author: – Washington University School of Medicine

Co-Author: – Washington University School of Medicine

Drug Utilization Research

9:15 AM – 9:30 AM CEST

Impact of COVID-19 Pandemic on the Prescription Trends of Antiseizure Medications

Location: Congress Hall D4

Presenting Author: – The University of Manitoba

Co-Author: – The University of Manitoba

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences University of Manitoba, Winnipeg, Canada.

Co-Author: – The University of Manitoba

Drug Utilization Research

9:30 AM – 9:45 AM CEST

The Effect of the COVID-19 Pandemic on Medicines Utilisation in England

Location: Congress Hall D4

Presenting Author: – Lane Clark and Peacock

Co-Author: – Lane Clark and Peacock

Drug Utilization Research

9:45 AM – 10:00 AM CEST

Impact of COVID-19 on Psychotropic Medication Use Among Children and Adolescents Receiving Mental Health Services

Location: Congress Hall D4

Presenting Author: – University of Maryland School of Pharmacy

Co-Author: – University of Maryland School of Pharmacy

Co-Author: – Pharmaceutical Health Services Research, School of Pharmacy

Drug Utilization Research

8:30 AM – 10:00 AM CEST

Around the World With Real-World Evidence

Location: C1M0

Moderator: – Evidera | PPD

Moderator: – CSM, NDORMS, University of Oxford

Drug Effectiveness

8:30 AM – 8:45 AM CEST

HIV Pre-exposure Prophylaxis (PrEP) Effectiveness in the Real World: A Nested Case-control Study Among 46,706 Men at High Risk of HIV Infection in France

Location: C1M0

Presenting Author: – EPI-Phare

Co-Author: – French National Agency for Medicines and Health Products Safety

Co-Author: – EPI-PHARE

Drug Effectiveness

8:30 AM – 10:00 AM CEST

The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients

Location: C1M0

Presenting Author: – Target RWE

Co-Author: – Target RWE

Co-Author: – Duke University

Drug Effectiveness

8:45 AM – 9:00 AM CEST

Use of Central Nervous System Drugs in Combination with Selective Serotonin Reuptake Treatment: A Bayesian Screening Study for Risk of Suicidal Behavior

Location: C1M0

Presenting Author: – Karolinska Institutet

Co-Author: – Karolinska Institutet

Co-Author: – University of Chicago

Co-Author: – Indiana University

Co-Author: – Karolinska Institutet

Co-Author: – University of Oxford

Drug Effectiveness

9:00 AM – 9:15 AM CEST

Long-acting Injectable Antipsychotics and Risk of Treatment Failure in a Population-based Cohort

Location: C1M0

Presenting Author: – The University of Manitoba

Co-Author: – Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba

Co-Author: – Drug Intelligence, Optimization, Outcomes and Strategy Branch, Pharmaceutical Services Division, B.C. Ministry of Health

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences University of Manitoba, Winnipeg, Canada.

Drug Effectiveness

9:30 AM – 9:45 AM CEST

Association Between Very High PD-L1 Expression versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-small Cell Lung Cancer

Location: C1M0

Presenting Author: – IQVIA

Co-Author: – Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania

Co-Author: – 1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania

Co-Author: – Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania

Drug Effectiveness

9:45 AM – 10:00 AM CEST

Does Hydroxychloroquine Prevent Cardiovascular Events in Systemic Lupus Erythematosus Patients?

Location: C1M0

Presenting Author: – Paris Saclay

Co-Author: – Re-Meds France

Co-Author: – CHU Rouen, Department of Biostatistics and Clinical Research, F-76000 Rouen France

Co-Author: – Faculty of Pharmacy, Université de Montréal

Co-Author: – London School of Hygiene & Tropical Medicine

Drug Effectiveness

8:30 AM – 10:00 AM CEST

SGLT2s and Cardiovascular Endpoints

Location: C1M1

Moderator: – Patient Centered Outcomes Research Institute

Moderator: – University of Southern Denmark

Drug Effectiveness

8:30 AM – 8:45 AM CEST

Sodium-glucose Co-transporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study

Location: C1M1

Presenting Author: – Karolinska Institutet

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm

Co-Author: – Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Co-Author: – Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

Co-Author: – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Co-Author: – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Co-Author: – Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Drug Effectiveness

8:45 AM – 9:00 AM CEST

Cardiovascular Outcomes in Patients with Type 2 Diabetes Who Added Either GLP1 Receptor Agonists or DPP4 Inhibitors to SGLT2 Inhibitor Therapy

Location: C1M1

Presenting Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Rutgers Center for Pharmacoepidemiology and Treatment Science

Co-Author: – Brigham and Women's Hospital

Co-Author: – Massachusetts General Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Effectiveness

9:00 AM – 9:15 AM CEST

Cardiovascular Effectiveness of Sodium—glucose Cotransporter 2 Inhibitors (SGLT-2i) and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) in Routine Care of Frail People with Type 2 Diabetes

Location: C1M1

Presenting Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Effectiveness

9:15 AM – 9:30 AM CEST

Cardiovascular Effectiveness of SGLT2 Inhibitors: Head-to-head Comparisons

Location: C1M1

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Massachusetts General Hospital

Co-Author: – Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Effectiveness

9:30 AM – 9:45 AM CEST

Cardiovascular Effectiveness of Empagliflozin vs. Glucagon-like peptide-1 Receptor Agonists or Liraglutide in the EMPRISE Study

Location: C1M1

Presenting Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Massachusetts General Hospital

Co-Author: – Brigham and Women's Hospital

Co-Author: – Harvard Medical School, Brigham and Women's Hospital

Co-Author: – Boehringer Ingelheim International GmbH

Co-Author: – Brigham and Women's Hospital

Co-Author: – Lilly Deutschland

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Effectiveness

9:45 AM – 10:00 AM CEST

Using Iterative Causal Forest to Identify Heterogeneous Treatment Effects: Sodium-glucose Cotransporter-2 inhibitors versus Glucagon-like Peptide-1 Receptor Agonists on Hospitalization for Heart Failure

Location: C1M1

Presenting Author:

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Drug Effectiveness

8:30 AM – 10:00 AM CEST

Welcoming Novel Methods in Pregnancy Research

Location: C1M2

Moderator: – University of Oslo

Moderator: – U.S. Centers for Disease Control and Prevention

Pregnancy and Lactation

8:30 AM – 8:45 AM CEST

Associations of Prenatal Exposure to Antibiotics and Paracetamol with Trajectories of Wheezing up to 2 Years of Age

Location: C1M2

Presenting Author: – Radboud university medical center

Co-Author: – Radboud university medical center

Co-Author: – Utrecht University

Co-Author: – Radboud university medical center

Pregnancy and Lactation

8:45 AM – 9:00 AM CEST

Development and Validation of Claims-based Algorithms for Estimating Gestational Age of Spontaneous Abortion and Termination

Location: C1M2

Presenting Author: – Harvard Medical School

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Harvard School of Public Health

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration

Co-Author: – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Co-Author: – US Food and Drug Administration

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Pregnancy and Lactation

9:00 AM – 10:00 AM CEST

Estimating the Association Between Initial Postpartum Discharge Opioid Prescription Dose and Subsequent Opioid Use: The Role of Different Modeling Strategies

Location: C1M2

Presenting Author: – Vanderbilt University Medical Center

Co-Author: – Vanderbilt University Medical Center

Pregnancy and Lactation

9:15 AM – 9:30 AM CEST

Hierarchical Clustering Analysis to Inform Classification of Congenital Malformations for Surveillance of Medication Safety in Pregnancy

Location: C1M2

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Harvard School of Public Health

Co-Author: – Harvard Medical School/Brigham & Women's Hospital

Co-Author: – Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA

Co-Author: – Medical Genetics Unit, MassGeneral Hospital for Children, Boston, MA , USA

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Harvard Medical School

Pregnancy and Lactation

9:30 AM – 9:45 AM CEST

A Novel Framework to Assess Reproductive Toxicity: Pregnancy Outcomes Intensive Monitoring (PRIM)

Location: C1M2

Presenting Author: – Novartis Pharma AG

Co-Author: – Novartis Pharma AG

Pregnancy and Lactation

9:45 AM – 10:00 AM CEST

Quantification of Medication-mediated Effects on Pregnancy Outcome in Women with Rheumatic Conditions

Location: C1M2

Presenting Author: – University of California, San Diego

Co-Author: – HealthPartners Institute

Co-Author: – University of California San Diego

Co-Author: – University of California, San Diego

Pregnancy and Lactation

10:00 AM – 10:30 AM CEST

Break/Exhibits/Posters

Location: Hall C

10:30 AM – 12:00 PM CEST

Shaping the Future of Pharmacoepidemiology

Location: C1M5

Presenting Author: – Jazz Pharmaceuticals

Author: – PEPI Consultancy Limited

Author: – University of Florida

Author: – GSK

Author: – European Medicines Agency

Author: – University of Technology Sydney

Author: – US Food and Drug Administration

Author: – University of Utrecht

Author: – AbbVie

Author: – Optum Epidemiology

Author: – National Taiwan University

Author: – University of Missouri–Kansas City

Author: – FISPE

Author: – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA

Methods in Pharmacoepidemiology

10:30 AM – 12:00 PM CEST

What Do Real World Data Validation Best Practices Look Like? Operationalizing Guidance for Real-world Studies Intended for Decision-making

Location: Congress Hall D2

Presenting Author: – Aetion, Inc

Author: – Eli Lilly & Company

Author: – Harvard Pilgrim Health Care Institute

Author: – National Institute for Health and Care Excellence

Author: – TriNetX

Author: – Reagan-Udall Foundation for the FDA

Methods in Pharmacoepidemiology

10:30 AM – 12:00 PM CEST

Updating the Public on COVID-19 Vaccine Safety - Considerations for Pharmacoepidemiologists

Location: Congress Hall D5

Presenting Author: – Copenhagen Centre for Regulatory Science, University of Copenhagen

Author: – European Medicines Agency

Author: – UNC Gillings School of Global Public Health

Author: – University of Sydney

Author: – University of Southern Denmark

Author: – University Medical Center Groningen

Benefit-Risk Assessment, Communication, and Evaluation (BRACE)

10:30 AM – 12:00 PM CEST

Emulation Differences versus Bias: Implications of Large-scale Emulation of Randomized Clinical Trials Using Clinical Practice Data (RCT-DUPLICATE)

Location: C1M0

Presenting Author: – Harvard Medical School/Brigham & Women's Hospital

Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Author: – European Medicines Agency

Author: – Association of Austrian Social Insurance Institutions Medical University of Vienna

Author: – Novartis

Methods in Pharmacoepidemiology

10:30 AM – 12:00 PM CEST

COVID-19 Vaccine Use During Pregnancy: Accelerating Innovative Evidence Generation Platforms to Meet Current and Future Challenges

Location: C1M1

Presenting Author: – Janssen Research & Development

Author: – Pregistry

Author: – AstraZeneca

Author: – Sanofi

Author: – Janssen

Author: – Novavax

Pregnancy and Lactation

12:00 PM – 1:30 PM CEST

ISPE Board of Directors' Lunch & Meeting

Location: Meeting Room 19

Chair: – Rutgers Center for Pharmacoepidemiology and Treatment Science

12:00 PM – 1:30 PM CEST

Lunch/Exhibits/Posters

Location: Hall C

12:15 PM – 1:15 PM CEST

Spotlight Poster Session C

Location: Hall E-South

1:30 PM – 3:00 PM CEST

Novel Approaches to Pharmacovigilance

Location: C1M5

Moderator: – UNC Gillings School of Global Public Health

Moderator: – OM1

Pharmacovigilance

1:30 PM – 1:45 PM CEST

Surveillance of Antidepressant Safety (SADS): Comparison of Signal Detection of Serious Medical Events Using Tree-based Scan Statistics and Repeated Cohort Studies

Location: C1M5

Presenting Author: – University of Copenhagen

Co-Author: – Department of Applied Mathematics and Computer Science, Technical University of Denmark

Co-Author: – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG Utrecht, The Netherlands

Co-Author: – Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen

Co-Author: – University of Copenhagen

Pharmacovigilance

1:45 PM – 2:00 PM CEST

Myocarditis and Pericarditis Associated with SARS-CoV-2 Vaccines in Four European Countries Using Large Electronic Health Care Data Sources: A Population-based Descriptive Cohort and a Nested Self-controlled Risk Interval Study

Location: C1M5

Presenting Author: – University Medical Center Utrecht

Co-Author: – Utrecht University

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – Agenzia Regionale di Sanita’, Florence Toscana, Italy

Co-Author: – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands

Co-Author: – Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, the Netherlands

Co-Author: – Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands

Co-Author: – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT

Co-Author: – AEMPS (Spanish Agency of Medicines and Medical Devices)

Co-Author: – Agenzia Reg Della Sanit

Co-Author: – PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands

Co-Author: – Faculty of Medicine. Department of Public Health. Complutense University of Madrid

Co-Author: – AEMPS

Co-Author: – Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands

Co-Author: – PHARMO Institute

Co-Author: – ARS Toscana, Florence, Italy

Co-Author: – Utrecht University

Co-Author: – PHARMO Institute

Co-Author: – University of Utrecht

Co-Author: – University Medical Center Utrecht

Pharmacovigilance

2:00 PM – 2:15 PM CEST

Screening for Statin-related Prescribing Cascades Using High-throughput Sequence Symmetry Analysis

Location: C1M5

Presenting Author: – University of Florida College of Pharmacy

Co-Author: – University of Florida - Department of Pharmaceutical Outcomes & Policy

Co-Author: – University of Florida College of Pharmacy

Co-Author: – Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA

Co-Author: – University of Florida College of Medicine

Co-Author: – 2. Department of Pharmacotherapy & Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, United States

Pharmacovigilance

2:15 PM – 2:30 PM CEST

Detecting Adverse Drug Events in Dermatology Through Natural Language Processing of Physician Notes

Location: C1M5

Presenting Author: – OMNY Health

Co-Author: – OMNY Health

Co-Author: – John Snow Labs

Pharmacovigilance

2:30 PM – 2:45 PM CEST

Preliminary Results from HERO-together: A Post-emergency Use Authorization Observational Cohort Study to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine in US Healthcare Workers and Community Members

Location: C1M5

Presenting Author: – Duke Clinical Research Institute

Co-Author: – Pfizer, Inc

Co-Author: – Duke Clinical Research Institute

Co-Author: – Pfizer, Inc

Co-Author: – Verily Life Sciences

Co-Author: – Duke Clinical Research Institute

Pharmacovigilance

2:45 PM – 3:00 PM CEST

Use of Anxiolytic, Hypnotic and Antidepressant Drugs After Dispensation of a Levonorgestrel 52 mg Intra-uterine System Compared to a 19.5 mg Intra-uterine System: A Nationwide Matched-cohort Study

Location: C1M5

Presenting Author: – French National Agency for Medicines and Health Products Safety

Co-Author: – Epiphare

Co-Author: – French National Agency for Medicines and Health Products Safety

Co-Author: – Gynaecology Unit and Reference Center for Rare Diseases of Genital Development, AP-HP, University Paris Saclay, Bicêtre Hospital, Le Kremlin-Bicêtre, France

Co-Author: – EPI-PHARE

Co-Author: – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France

Pharmacovigilance

1:30 PM – 3:00 PM CEST

Fractures and Osteoporosis Medication

Location: Congress Hall D2

Moderator: – RTI Health Solutions

Moderator: – The Ohio State University

Drug Effectiveness

1:30 PM – 1:45 PM CEST

Concurrent Use of Prescription Opioids with Other Medications and Risk of Fall and Fracture in Rheumatoid Arthritis Patients

Location: Congress Hall D2

Presenting Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Harvard Medical School, Brigham and Women's Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Drug Effectiveness

1:45 PM – 2:00 PM CEST

Effectiveness of Osteoporosis Medications on the Risk of Fracture: A French Population-based Cohort Study

Location: Congress Hall D2

Presenting Author: – Bordeaux PharmacoEpi

Co-Author: – Amgen Ltd, UK

Co-Author: – Université de paris, INSERM U1153, hôpital Cochin, rhumatologie, 75014, Paris

Co-Author: – CHU Bordeaux-Tripode, Service de Rhumatologie, 33076 Bordeaux

Co-Author: – Aetion Inc., Barcelona, Spain

Co-Author: – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France

Co-Author: – Bordeaux PharmacoEpi

Co-Author: – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France

Drug Effectiveness

2:00 PM – 2:15 PM CEST

A Translational Approach to Study Drug-Drug Interaction with Hormonal Contraceptives: From Pharmacoepidemiology to Mechanistic Modelling

Location: Congress Hall D2

Presenting Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – University of Florida

Co-Author: – Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA

Co-Author: – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA

Co-Author: – University of Florida

Drug Effectiveness

2:15 PM – 2:30 PM CEST

Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data

Location: Congress Hall D2

Presenting Author: – Jenny Guadamuz

Co-Author: – Flatiron Health, Inc

Co-Author: – University of Utah School of Medicine

Co-Author: – The University of Chicago

Co-Author: – University of Illinois at Chicago

Co-Author: – Flatiron Health

Co-Author: – Huntsman Cancer Institute at the University of Utah

Co-Author: – Flatiron Health

Drug Effectiveness

2:30 PM – 2:45 PM CEST

The Difference Between Pregabalin and Gabapentin in the Risk of Fragility Fractures - A Nationwide High-dimensional Propensity Score Matched Cohort Study

Location: Congress Hall D2

Presenting Author: – University of Southern Denmark

Co-Author: – Department of Clinical Pharmacology, Odense University Hospital

Co-Author: – Department of Clinical Pharmacology, Odense University Hospital, Denmark and Department of Clinical Research, University of Southern Denmark, Denmark

Co-Author: – University of Southern Denmark

Safety End Points

2:45 PM – 3:00 PM CEST

Treatment Heterogeneity in Comparative Effectiveness of Teriparatide vs. Bisphosphonates: Multi-database Cohort Study

Location: Congress Hall D2

Presenting Author: – Erasmus University Medical Center

Co-Author: – University of Oxford

Co-Author: – Erasmus University Medical Center

Co-Author: – CSM, NDORMS, University of Oxford

Co-Author: – Erasmus University Medical Center, Rotterdam, The Netherlands

Drug Effectiveness

1:30 PM – 3:00 PM CEST

Use it or Lose Out: Trends in Anti-Cancer and Biologic Utilization

Location: Congress Hall D5

Moderator: – Eli Lilly and Company

Moderator: – Regeneron Pharmaceuticals

Drug Utilization Research

1:30 PM – 1:45 PM CEST

Utilization Patterns of Systemic Immunomodulating Drugs in Patients with Atopic Dermatitis in Clinical Practice

Location: Congress Hall D5

Presenting Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Drug Utilization Research

1:45 PM – 2:00 PM CEST

Trends in Access to Essential Cancer Medicines in Low and Middle Income Countries, 2015-2020

Location: Congress Hall D5

Presenting Author:

Co-Author: – University of Southern California

Co-Author: – Center for Global Development

Drug Utilization Research

2:00 PM – 2:15 PM CEST

End-of-life Endocrine Treatment of Older Hormone Receptor-positive Metastatic Breast Cancer Patients: A Nationwide Swedish Retrospective Cohort Study

Location: Congress Hall D5

Presenting Author: – Karolinska Institutet

Co-Author: – Department of Medical Epidemiology and Biostatistics, Karolinska Institute

Co-Author: – Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology; Clinical Oncology, Faculty of Medicine, Uppsala University Hospital, Uppsala, 751 85, Sweden

Co-Author: – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Drug Utilization Research

2:15 PM – 2:30 PM CEST

Real-World Treatment Patterns Before and After Receiving PD-L1 Test Results in Patients with Advanced Non-small Cell Lung Cancer (aNSCLC)

Location: Congress Hall D5

Presenting Author: – Regeneron Pharmaceuticals

Co-Author: – Center for Cancer Immunotherapy, Duke University School of Medicine, Durham, NC, USA

Co-Author: – Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA

Co-Author: – Center for Cancer Immunotherapy, Duke University School of Medicine, Durham, NC, USA

Co-Author: – Regeneron Pharmaceuticals

Co-Author: – Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA

Drug Utilization Research

2:30 PM – 2:45 PM CEST

Triptan Consumption Before and After the Initiation of an Anti-CGRP mAb: A Descriptive Drug Utilization Study in Tuscany Region, Italy

Location: Congress Hall D5

Presenting Author: – Agenzia Regionale di Sanit� Toscana

Co-Author: – ARS Toscana, Florence, Italy

Co-Author: – Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy

Co-Author: – Agenzia Reg Della Sanit

Co-Author: – Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy

Co-Author: – Agenzia Regionale di Sanità della Toscana

Drug Utilization Research

2:45 PM – 3:00 PM CEST

The Association Between Trajectories of Adherence to Endocrine Therapy and the Risk of Breast Cancer Recurrence Among Nonmetastatic Breast Cancer Survivors

Location: Congress Hall D5

Presenting Author: – University of North Carolina at Chapel Hill

Co-Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida

Co-Author: – University of Florida

Co-Author: – Department of Medicine, College of Medicine, University of Florida

Co-Author: – University of Florida

Co-Author: – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida

Drug Utilization Research

1:30 PM – 3:00 PM CEST

Safety Issues Concerning DM and Antidiabetic Drugs

Location: C1M0

Moderator: – School of Pharmacy, Sungkyunkwan University

Moderator: – UMass Chan Medical School

Safety End Points

1:30 PM – 1:45 PM CEST

Long-acting Insulin Analogues versus Neutral Protamine Hagedorn Insulin and the Risk of Severe Hypoglycemia Among Patients in Type 2 Diabetes in the United Kingdom

Location: C1M0

Presenting Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Co-Author: – McGill University

Co-Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Safety End Points

2:00 PM – 2:15 PM CEST

The Comparative Safety of Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis

Location: C1M0

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Massachusetts General Hospital

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Safety End Points

2:15 PM – 2:30 PM CEST

Risk of New-onset Type 2 Diabetes in Antidepressant Users: A Population-based Cohort Study in Denmark

Location: C1M0

Presenting Author: – Copenhagen Centre for Regulatory Science, University of Copenhagen

Co-Author: – University of Copenhagen

Co-Author: – Section of Biostatistics, Department of Public Health, University of Copenhagen

Disease Epidemiology/Clinical Course

2:30 PM – 2:45 PM CEST

Risk of Hypoglycemia with Sodium Glucose cotransporter-2 Inhibitors vs. Alternative Glucose Lowering Medications in Patients with and Without Baseline Use of Insulin or Sulfonylurea

Location: C1M0

Presenting Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Massachusetts General Hospital

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Safety End Points

2:45 PM – 3:00 PM CEST

Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: A Population-based Cohort Study

Location: C1M0

Presenting Author: – McGill University, Department of Medicine

Co-Author: – Centre for Clinical Epidemiology, Lady Davis Institute

Co-Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Co-Author: – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Co-Author: – McGill University

Co-Author: – Lady Davis Institute

Safety End Points

1:30 PM – 3:00 PM CEST

Evaluating the Vaccines Against the Nasty Bugs: Safety First Round II

Location: C1M1

Moderator: – European Medicines Agency

Moderator: – Washington University School of Medicine

Drug Utilization Research

1:30 PM – 1:45 PM CEST

COVID-19 Vaccination During Pregnancy and Risk of Preterm Birth, Small-for-gestational-age Birth, and Stillbirth

Location: C1M1

Presenting Author: – University of Ottawa

Co-Author: – BORN Ontario

Co-Author: – Annette Regan

Co-Author: – Norwegian Institute of Public Health

Co-Author: – University of Ottawa

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – BORN Ontario

Co-Author: – Department of Pediatrics, Mount Sinai Hospital and University of Toronto

Co-Author: – 15 Department of Obstetrics and Gynecology, University of Ottawa

Co-Author: – 15 Department of Obstetrics and Gynecology, McMaster University

Co-Author: – BORN Ontario

Co-Author: – Sunnybrook Health Sciences Centre and University of Toronto

Co-Author: – Public Health Ontario and University of Toronto

Co-Author: – ICES

Co-Author: – Public Health Ontario and University of Toronto

Co-Author: – BORN Ontario

Co-Author: – Department of Medicine, University of Ottawa

Co-Author: – Faculty of Nursing, University of Alberta

Co-Author: – BORN Ontario

Vaccines

1:45 PM – 2:00 PM CEST

Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination

Location: C1M1

Presenting Author: – Kaiser Permanente

Co-Author: – Kaiser Permanente Northern California, Vaccine Study Center

Co-Author: – Kaiser Permanente Northern California Division of Research

Co-Author: – Marshfield Clinic Research Institute, Marshfield

Co-Author: – Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin

Co-Author: – Kaiser Permanente Northern California, Vaccine Study Center

Co-Author: – Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon

Co-Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Research and Evaluation, Kaiser Permanente Southern California

Co-Author: – Institute for Health Research, Kaiser Permanente Colorado

Co-Author: – Denver Health Medical Center

Co-Author: – HealthPartners Institute

Co-Author: – Harvard Pilgrim Health Care Institute

Vaccines

2:00 PM – 2:15 PM CEST

COVID-19 Vaccination and Acute Neurological Events in England: A Self-controlled Case Series Using the OpenSAFELY Platform

Location: C1M1

Presenting Author: – London School of Hygiene and Tropical Medicine

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool AND Division of Neurology, Walton Centre NHS Foundation Trust, Liverpool, L9 7LJ

Co-Author: – NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool AND Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, L7 8XP

Co-Author: – Medicine and Healthcare products Regulatory Agency (UK)

Co-Author: – UK Health Security Agency

Co-Author: – The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG

Co-Author: – Department of Medical Statistics, London School of Hygiene and Tropical Medicine

Co-Author: – . NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool AND Division of Neurology, Walton Centre NHS Foundation Trust, Liverpool, L9 7LJ

Co-Author: – UK Health Security Agency

Co-Author: – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT

Co-Author: – The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG

Co-Author: – London School of Hygiene and Tropical Medicine

Vaccines

2:15 PM – 2:30 PM CEST

Assessment of the Risk of Myocardial Infarction, Stroke, and Pulmonary Embolism Following Different COVID-19 Vaccines in Adults Under 75 Years of Age in France

Location: C1M1

Presenting Author: – Epiphare

Co-Author: – French National Agency for Medicines and Health Products Safety

Co-Author: – Epiphare

Co-Author: – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France

Co-Author: – School of Mathematics and Statistics, The Open University

Co-Author: – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France

Co-Author: – EPI-PHARE

Vaccines

2:30 PM – 2:45 PM CEST

Genetic Risk and Incident Venous Thromboembolism in Middle-aged and Older Adults Following COVID-19 Vaccination

Location: C1M1

Presenting Author: – CSM, NDORMS, University of Oxford

Co-Author: – Boehringer Ingelheim Pharma GmbH & Co. KG

Co-Author: – CSM, NDORMS, University of Oxford

Co-Author: – Department of Epidemiology and Biostatistics, Imperial College London, London, UK.

Co-Author: – Infectious Diseases Department & irsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Catalonia, Spain

Co-Author: – CSM, NDORMS, University of Oxford

Vaccines

2:45 PM – 3:00 PM CEST

mRNA COVID-19 Vaccination Early in Pregnancy and Risk of Spontaneous Abortion in an International Pregnancy Registry

Location: C1M1

Presenting Author: – Harvard School of Public Health

Co-Author: – Pregistry

Co-Author: – Harvard School of Public Health

Vaccines

1:30 PM – 3:00 PM CEST

Lightning Session 3

Location: C1M2

Moderator: – University of North Carolina at Chapel Hill

Moderator: – Agenzia Reg Della Sanit

Moderator: – Merck & Co., Inc.

Moderator: – University of Southern Denmark

Lightning Session 3

1:30 PM – 1:35 PM CEST

The Impact of Electronic Health Record Discontinuity on Prediction Modeling

Location: C1M2

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author:

Co-Author: – 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s

Informatics

1:35 PM – 1:40 PM CEST

Target Fishing and Drug Repurposing for Pancreatic Ductal Adenocarcinoma: An Integrated Bioinformatic and Computational Approach

Location: C1M2

Presenting Author: – M. S. RAMAIAH UNIVERSITY OF APPLIED SCIENCES

Co-Author: – Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences

Co-Author: – Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal

Informatics

1:40 PM – 1:45 PM CEST

Using Network Analysis Modularity to Represent Health Code Systems in Machine Learning Models

Location: C1M2

Presenting Author: – UiT The Arctic University of Norway

Co-Author: – University of Tromso

Co-Author: – The Arctic University of Norway

Informatics

1:45 PM – 1:50 PM CEST

Web and Social Media Listening Using AI/NLP for COVID-19 Vaccine Safety Monitoring

Location: C1M2

Presenting Author:

Co-Author: – Sanofi US

Co-Author: – Sanofi

Informatics

2:00 PM – 2:05 PM CEST

Temporal Changes in Incidence of Acute Pyelonephritis: A 19-year Population-based Danish Cohort Study

Location: C1M2

Presenting Author: – Department of Clinical Epidemiology, Aarhus University

Co-Author: – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark

Co-Author: – Department of Clinical Medicine, Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Denmark

Co-Author: – Department of Clinical Medicine, Aarhus University, Denmark

Co-Author: – Department of Clinical Epidemiology, Aarhus University

Disease Epidemiology

2:05 PM – 2:10 PM CEST

Predicting Risks of Intracranial Bleeding in Older Adults with Atrial Fibrillation to Aid Prescribing Decisions

Location: C1M2

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author:

Co-Author: – Brigham and Women's Hospital

Disease Epidemiology

2:10 PM – 2:15 PM CEST

Estimating the Incidence of Co-occurring Thrombosis and Thrombocytopenia in a Healthcare Database

Location: C1M2

Presenting Author: – Janssen Pharmaceutical company

Co-Author: – Epidemiology, Office of the Chief Medical Officer, Johnson & Johnson

Co-Author: – School of Health Care Administration, Taipei Medical University, Taiwan

Co-Author: – Epidemiology, Office of the Chief Medical Officer, Johnson & Johnson Research & Development

Co-Author: – Janssen China Research & Development

Co-Author: – School of Health Care Administration, Taipei Medical University

Disease Epidemiology

2:15 PM – 2:20 PM CEST

Individualized Treatment Rule Identification in Heart Failure Patients Using Precision-medicine Methods

Location: C1M2

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – University of North Carolina at Chapel Hill

Disease Epidemiology

2:30 PM – 2:35 PM CEST

Exposure to Known or Suspected Teratogenic Drugs Prior to Conception in a Commercially Insured Population of Pregnant Women

Location: C1M2

Presenting Author: – Optum Epidemiology

Co-Author: – Optum Epidemiology

Pregnancy and Lactation

2:35 PM – 2:40 PM CEST

Antibiotic Use in Early Pregnancy and Risk of Gestational Diabetes Mellitus: A Nationwide Cohort Study of 3 Million Pregnancies

Location: C1M2

Presenting Author: – Sungkunkwan University

Co-Author: – School of Pharmacy, SKKU

Co-Author: – Division of Life Sciences, Korea University

Co-Author: – School of Pharmacy, Sungkyunkwan University

Pregnancy and Lactation

2:40 PM – 2:45 PM CEST

Associations of Prenatal Depression and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment with Early Child Development

Location: C1M2

Presenting Author: – Kaiser Permanente Northern California Division of Research

Co-Author: – Kaiser Permanente Northern California Division of Research

Co-Author: – The Permanente Medical Group

Co-Author: – Kaiser Permanente

Co-Author: – Kaiser Permanente Northern California Division of Research

Co-Author: – The Permanente Medical Group

Co-Author: – Kaiser Permanente Northern California Division of Research

Co-Author: – The Permanente Medical Group

Pregnancy and Lactation

2:45 PM – 2:50 PM CEST

Associations of prenatal exposure to non-steroidal anti-inflammatory drugs with preterm birth and small-for-gestational age among women with autoimmune disorders

Location: C1M2

Presenting Author:

Co-Author: – University of California, San Diego

Co-Author: – UC San Diego, Department of Pediatrics

Co-Author: – University of California, San Diego

Pregnancy and Lactation

3:00 PM – 3:15 PM CEST

Break/Exhibits/Posters

Location: Hall C

3:15 PM – 4:45 PM CEST

Hot Topic Session: How Can We Mitigate Publication of Poorly Conducted RWE Studies? Keynote Session [Plenary]

Location: Congress Hall D4

Moderator: – University of Florida

Speaker: – Aarhus University

Speaker: – TriNetX

Speaker: – UNC Gillings School of Global Public Health

Speaker: – Evidera | PPD

4:45 PM – 5:30 PM CEST

The Final Word

Location: Congress Hall D4

Lead Speaker: – University of Southern Denmark

Speaker: – University of Southern Denmark

Speaker: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

5:45 PM – 6:45 PM CEST

2023 Scientific Program Committee

Location: Meeting Room 20

Chair: – McGill Dept of Epidemiology, Biostatistics and Occupational Health